Annual Short Term Debt
$6.59 M
+$2.91 M+79.11%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual short term debt is $6.59 million, with the most recent change of +$2.91 million (+79.11%) on December 31, 2023.
- During the last 3 years, TCRX annual short term debt has risen by +$5.18 million (+365.94%).
- TCRX annual short term debt is now at all-time high.
Performance
TCRX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$3.90 M
-$10.05 M-72.06%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly short term debt is $3.90 million, with the most recent change of -$10.05 million (-72.06%) on September 30, 2024.
- Over the past year, TCRX quarterly short term debt has dropped by -$1.59 million (-28.95%).
- TCRX quarterly short term debt is now -72.06% below its all-time high of $13.95 million, reached on June 30, 2024.
Performance
TCRX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
TCRX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +79.1% | -28.9% |
| 3 y3 years | +365.9% | -28.9% |
| 5 y5 years | +1388.3% | -28.9% |
TCRX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +299.3% | -72.1% | +136.1% |
| 5 y | 5-year | at high | +1388.3% | -72.1% | +175.5% |
| alltime | all time | at high | +1388.3% | -72.1% | +175.5% |
TScan Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.90 M(-72.1%) |
| Jun 2024 | - | $13.95 M(+37.6%) |
| Mar 2024 | - | $10.13 M(+53.7%) |
| Dec 2023 | $6.59 M(+79.1%) | $6.59 M(+20.2%) |
| Sep 2023 | - | $5.49 M(+30.3%) |
| Jun 2023 | - | $4.21 M(+9.7%) |
| Mar 2023 | - | $3.84 M(+4.2%) |
| Dec 2022 | $3.68 M | $3.68 M(+105.1%) |
| Sep 2022 | - | $1.79 M(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.75 M(+2.8%) |
| Mar 2022 | - | $1.70 M(+2.8%) |
| Dec 2021 | $1.65 M(+16.7%) | $1.65 M(+1.9%) |
| Sep 2021 | - | $1.62 M(+2.9%) |
| Jun 2021 | - | $1.57 M(+2.9%) |
| Mar 2021 | - | $1.53 M(+8.1%) |
| Dec 2020 | $1.42 M(+219.4%) | - |
| Dec 2020 | - | $1.42 M |
| Dec 2019 | $443.00 K | - |
FAQ
- What is TScan Therapeutics annual short term debt?
- What is the all time high annual short term debt for TScan Therapeutics?
- What is TScan Therapeutics annual short term debt year-on-year change?
- What is TScan Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for TScan Therapeutics?
- What is TScan Therapeutics quarterly short term debt year-on-year change?
What is TScan Therapeutics annual short term debt?
The current annual short term debt of TCRX is $6.59 M
What is the all time high annual short term debt for TScan Therapeutics?
TScan Therapeutics all-time high annual short term debt is $6.59 M
What is TScan Therapeutics annual short term debt year-on-year change?
Over the past year, TCRX annual short term debt has changed by +$2.91 M (+79.11%)
What is TScan Therapeutics quarterly short term debt?
The current quarterly short term debt of TCRX is $3.90 M
What is the all time high quarterly short term debt for TScan Therapeutics?
TScan Therapeutics all-time high quarterly short term debt is $13.95 M
What is TScan Therapeutics quarterly short term debt year-on-year change?
Over the past year, TCRX quarterly short term debt has changed by -$1.59 M (-28.95%)